FirstGroup plc - Notification of Directors' Interests in Shares
Each Non-Executive Director of the Company (other than Audrey Baxter and Colin
Hood who receive all of their fees in the form of shares in the Company) has
elected to receive 40% of his fees in the form of shares in the Company. Tim O'
Toole, Chief Executive, has elected to receive a fixed small amount of part of
his benefits in relation to his remuneration each month in the form of shares
in the Company. Arrangements have been made for these shares to be purchased on
their behalf in the market on a regular basis.
Purchases took place on 22 July 2011 in accordance with standing instructions
as follows:
Director Ordinary Shares of 5 pence each
Martin Gilbert 2,010
Audrey Baxter 779
David Begg 444
Colin Hood 649
Tim O' Toole 125
John Sievwright 533
Martyn Williams 190
Shares were purchased at a price of 370 pence per share.
The revised total beneficial holdings of the directors following these
transactions are:
Director Ordinary Shares of 5 pence each
Martin Gilbert 167,936
Audrey Baxter 32,959
David Begg 23,701
Colin Hood 15,780
Tim O' Toole 6,772
John Sievwright 48,191
Martyn Williams 9,015
22 July 2011
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.